Trichosporon asahii fungemia and COVID-19 co-infection: An emerging fungal pathogen; case report and review of the literature
With the evolving COVID-19 pandemic, increasing concerns about invasive fungal infections have been reported particularly with the use of potent immunosuppressant medications to treat the immunological storms in patients with severe COVID-19 illnesses. Trichosporon asahii (T. asahii) is an emerging...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | IDCases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214250921002006 |
_version_ | 1818717790600691712 |
---|---|
author | Gawahir A. Ali Ahmed Husain Husam Salah Wael Goravey |
author_facet | Gawahir A. Ali Ahmed Husain Husam Salah Wael Goravey |
author_sort | Gawahir A. Ali |
collection | DOAJ |
description | With the evolving COVID-19 pandemic, increasing concerns about invasive fungal infections have been reported particularly with the use of potent immunosuppressant medications to treat the immunological storms in patients with severe COVID-19 illnesses. Trichosporon asahii (T. asahii) is an emerging highly resistant pathogen with considerable mortality particularly in critically ill patients and immunocompromised individuals. We describe a case of a 58-year-old patient who developed T. asahii fungemia after using immunosuppressant agents for his severe COVID-19 related cytokines release syndrome. Pseudohyphae, arthroconidia, and lateral blastoconidia were seen in the stain, and later confirmed to be T. asahii. Voriconazole successfully treated this multi-drug-resistant fungal infection. The clinical presentation, assessment, and management are reviewed to raise awareness of the circumstances leading to coinfection with this emerging resistant yeast. |
first_indexed | 2024-12-17T19:40:45Z |
format | Article |
id | doaj.art-c4d23b2d945c417aba71b0c4061fe40b |
institution | Directory Open Access Journal |
issn | 2214-2509 |
language | English |
last_indexed | 2024-12-17T19:40:45Z |
publishDate | 2021-01-01 |
publisher | Elsevier |
record_format | Article |
series | IDCases |
spelling | doaj.art-c4d23b2d945c417aba71b0c4061fe40b2022-12-21T21:35:00ZengElsevierIDCases2214-25092021-01-0125e01244Trichosporon asahii fungemia and COVID-19 co-infection: An emerging fungal pathogen; case report and review of the literatureGawahir A. Ali0Ahmed Husain1Husam Salah2Wael Goravey3Department of Infectious Diseases, Communicable Diseases Centre, Hamad Medical Corporation, Doha, QatarDepartment of Infectious Diseases, Communicable Diseases Centre, Hamad Medical Corporation, Doha, QatarDepartment of Laboratory Medicine and Pathology, HMC, Doha, QatarDepartment of Infectious Diseases, Communicable Diseases Centre, Hamad Medical Corporation, Doha, Qatar; Corresponding author at: Infectious Diseases Department, Hamad Medical Corporation, Doha, Qatar.With the evolving COVID-19 pandemic, increasing concerns about invasive fungal infections have been reported particularly with the use of potent immunosuppressant medications to treat the immunological storms in patients with severe COVID-19 illnesses. Trichosporon asahii (T. asahii) is an emerging highly resistant pathogen with considerable mortality particularly in critically ill patients and immunocompromised individuals. We describe a case of a 58-year-old patient who developed T. asahii fungemia after using immunosuppressant agents for his severe COVID-19 related cytokines release syndrome. Pseudohyphae, arthroconidia, and lateral blastoconidia were seen in the stain, and later confirmed to be T. asahii. Voriconazole successfully treated this multi-drug-resistant fungal infection. The clinical presentation, assessment, and management are reviewed to raise awareness of the circumstances leading to coinfection with this emerging resistant yeast.http://www.sciencedirect.com/science/article/pii/S2214250921002006COVID-19Trichosporon asahiiFungemiaVoriconazoleCentral venous catheters |
spellingShingle | Gawahir A. Ali Ahmed Husain Husam Salah Wael Goravey Trichosporon asahii fungemia and COVID-19 co-infection: An emerging fungal pathogen; case report and review of the literature IDCases COVID-19 Trichosporon asahii Fungemia Voriconazole Central venous catheters |
title | Trichosporon asahii fungemia and COVID-19 co-infection: An emerging fungal pathogen; case report and review of the literature |
title_full | Trichosporon asahii fungemia and COVID-19 co-infection: An emerging fungal pathogen; case report and review of the literature |
title_fullStr | Trichosporon asahii fungemia and COVID-19 co-infection: An emerging fungal pathogen; case report and review of the literature |
title_full_unstemmed | Trichosporon asahii fungemia and COVID-19 co-infection: An emerging fungal pathogen; case report and review of the literature |
title_short | Trichosporon asahii fungemia and COVID-19 co-infection: An emerging fungal pathogen; case report and review of the literature |
title_sort | trichosporon asahii fungemia and covid 19 co infection an emerging fungal pathogen case report and review of the literature |
topic | COVID-19 Trichosporon asahii Fungemia Voriconazole Central venous catheters |
url | http://www.sciencedirect.com/science/article/pii/S2214250921002006 |
work_keys_str_mv | AT gawahiraali trichosporonasahiifungemiaandcovid19coinfectionanemergingfungalpathogencasereportandreviewoftheliterature AT ahmedhusain trichosporonasahiifungemiaandcovid19coinfectionanemergingfungalpathogencasereportandreviewoftheliterature AT husamsalah trichosporonasahiifungemiaandcovid19coinfectionanemergingfungalpathogencasereportandreviewoftheliterature AT waelgoravey trichosporonasahiifungemiaandcovid19coinfectionanemergingfungalpathogencasereportandreviewoftheliterature |